The short-term kinetics of Zn turnover were studied in Irish setters with gluten-sensitive enteropathy and control dogs following intravenous injection of 0-25 mg 96.5 % enriched "ZnCJ. The ' OZn enrichment of serum was found closely to obey two-compartment kinetics and the derived two-compartment decay equation was used to calculate the size and turnover of the two initial rapidly exchanging pools of body Zn. In normal Irish setters isotopic Zn initially equilibrates with a pool (a) of size 1.27 (SD 046) pmol/kg and then with a second pool @) of size 683 (SD 1072) pmol/kg. The fractional turnover of pool (b) was approximately one eighth that of pool (a). Enteropathic dogs showed no reduction in the size of either rapidly exchangeable Zn pool, reduction in serum Zn concentration or abnormality in Zn balance and hence these results do not support the possibility of an underlying Zn deficiency in this disorder.
The assessment of Zn status is complicated because of the lack of accessible tissues which reflect overall body Zn content (Jackson et al. 1982; Golden, 1989) and because plasma or serum Zn concentrations are recognized to vary in stress conditions unassociated with Zn deficiency (Hallbrook & Hedelin, 1977) . Various workers have attempted to utilize isotopic techniques to overcome this problem (Jackson et al. 1988; Lowe et al. 1991 Lowe et al. , 1992 Lowe et al. , 1993 , but techniques for the application of isotopes to the routine study of Zn metabolism in dogs do not appear to have been described.
Radioactive isotopes of Zn have been used to develop complex mathematical models which describe Zn kinetics under various conditions in man and laboratory animals (Foster et al. 1979; Henkin et al. 1984; Wastney et al. 1986; Dunn & Cousins, 1989) . Such models have been used to help identify sites of regulation of Zn metabolism and calculate the size and turnover rate of body Zn pools. A simpler model describing Zn kinetics over a short time period (90 min) has been developed using 66Zn in the rat (Lowe et al. 1991) . Using this model it was shown that a rapidly exchanging pool of Zn is responsive to changes in dietary Zn intake, becoming signdicantly depleted in animals maintained on a Zn-deficient diet. s5Zn is a gamma emitter with a biological half-life of over 500 d (Hawkins et al. 1976 ). Due to safety considerations, its applicability in the study of Zn metabolism in domestic animals, such as dogs, is debatable.
Recent studies have shown that stable Zn isotopes can be used to study Zn kinetics in man (Jackson et al. 1984; Lowe et al. 1992 Lowe et al. , 1993 Miller et al. 1994) Gluten-sensitive enteropathy is a naturally occurring familial condition of Irish setter dogs manifested histologically by partial villus atrophy and intraepithelial lymphocyte infiltration (Hall & Batt, 1990~ ). An underlying abnormality of intestinal permeability has been reported (Hall & Batt, 1991) . The disease resembles coeliac disease in humans because recovery is possible if affected dogs are maintained on a gluten-free diet, and relapse occurs when dogs are orally challenged with gluten (Hall & Batt, 1992) . Although there are no overt signs of Zn deficiency in affected setters the finding of secondary but specific biochemical abnormalities, particularly reduced activities of Zn-containing enzymes such as alkaline phosphatase (EC 3.1 .3.1) and aminopeptidase N (EC 3.4.11 .2), led to the hypothesis that impaired nutrient absorption may cause marginal Zn deficiency (Hall & Batt, 1990b) . Findings of depleted body Zn pools in affected setters would support this hypothesis.
In the present study stable-isotope techniques have been used to study Zn turnover in Irish setter dogs. A simple kinetic model (based on that previously developed for rats and applied to human studies, Lowe et al. 1991 Lowe et al. , 1993 has been derived to describe the isotopic Zn turnover over 2 h post-injection of 70Zn. This has enabled the size and turnover rate of two rapidly exchanging Zn pools to be calculated. The technique was then applied to measure these variables in dogs with gluten-sensitive enteropathy. This information, along with the more commonly used indicators of Zn status, plasma Zn levels and Zn-balance measurements, has been used to evaluate the possibility that enteropathic animals may be marginally Zn deficient.
M A T E R I A L S A N D METHODS

Animals
Twelve Irish setter dogs aged 1-5-7 years were studied. Six of the dogs (four male and two female, aged 2-5 years) were healthy controls, the remaining six (five male, one female, aged 15-7 years) had been shown to be suffering from gluten-sensitive enteropathy by response to gluten withdrawal and relapse on gluten challenge (Hall & Batt, 1992) . The animals were routinely maintained on a gluten-containing diet and were given known amounts for 3 d before the kinetic study. The diet was composed of a known quantity of cereal mixer (Pedigree Chum mixer; Pedigree Petfoods, Melton Mowbray, Leicester, Leks.) and tinned meat ((Caesar'; Pedigree Petfoods). In order to determine the Zn content a sample of each meat portion and of the batch of mixer used were wet-ashed in concentrated HNO,. After dilution with deionized distilled water the Zn content was determined by atomic absorption spectrometry.
Kinetic study After the 3 d equilibration period on the controlled diet a cannula (19G Intracath; Dorset Medical Inc., Utah, USA) was inserted into the jugular vein of the dog and a baseline blood sample (10 ml) taken. A 0.25 mg portion of 96.5 YO enriched 70ZnC1, (Oakridge National Laboratory, Oakridge, TN, USA) in 5 ml isotonic sterile saline (9 g NaC1/1) was taken up in a syringe, weighed and injected into the cephalic vein. The syringe was reweighed and the exact dose administered was calculated. Blood samples (10 ml) were taken via the cannula at defined times (generally 2, 5, 10, 20, 30, 60, 90, 150 and 180min) after the isotope injection. Blood was collected into plain glass tubes and stored on ice before the serum was separated from the whole blood by centrifugation.
A portion of each serum sample was diluted tenfold with 3.1 M-HNO, and aspirated directly into the atomic absorption spectrometer for determination of total Zn concentration. The remainder of each serum sample was diluted with a surfactant (Triton X-100) and the 70Zn: s4Zn isotope ratios were determined by inductively coupled plasma mass spectrometry (ICP-MS ; AEA Analytical Services, Harwell, Oxon). Balance study After the kinetic study had been completed the dogs were placed in individual stainless steel metabolism cages. A faecal marker (carmine red) was given along with the first and after the last meal of a 48 h balance period. Faecal samples were collected from (and including) the first appearance of the carmine marker in the stool until (but not including) the appearance of the second marker. Complete urine collections were made throughout the balance period. The volume of urine collected was measured and a portion acidified with 1 ml concentrated HC1 per 100 ml urine and retained. Urine Zn content was determined by direct aspiration into an atomic absorption spectrometer. Faecal samples were weighed and homogenized, and a portion was wet-ashed in concentrated HNO,. After dilution with deionized distilled water the Zn content was determined by atomic absorption spectrometry.
Weighed portions of meat and cereal mixer were given separately twice daily (morning and evening); any meat or cereal not eaten was weighed and total food intake calculated.
Student's t test was used for statistical comparisons.
RESULTS
The body weights of the control dogs were higher than those with enteropathy (control 29-9 (SD 2.8) kg v. enteropathic 21.1 (SD 1.7) kg). Dietary Zn intake, total Zn output and the resulting balance for Zn are shown in Table 1 . These show no differences between the two groups when the effects of body weight are taken into consideration and the overall balance was not significantly different from zero for either group. Serum Zn concentrations were unchanged in the enteropathic group compared with the control animals (control 13-2 (SD 0.9) pmolll v. enteropathic 13.2 (SD 0.7) pmolll).
An example of the decay of ' OZn enrichment in the plasma of a control dog following intravenous injection is shown in Fig. 1 . Analysis of this curve by computer regression exponential functions and therefore followed two-compartment kinetics. The twocompartment equations derived from these data were then used to predict the data at different time points and a correlation between predicted and actual data is shown in Fig.  2 . This indicates the quality of the 'fit' of the data to the derived equation. and which are the primary contributors to the kinetics observed over the time period studied. The calculated size of the initial pool with which the ' OZn equilibrated (Q,), the size of the second exchangeable pool (Q,) together with the flux of Zn into pool (a) (Fu0) and the fractional turnover rates between the pools for the control dogs is shown in Fig. 3 (a) . The calculated sizes of pools (a) and (b) for the enteropathic dogs are shown in Fig. 3(b) and Table 2 . The mean value of Q, was significantly greater in the enteropathic group compared with the controls, although the individual data indicate that only three of the enteropathic dogs (J, K and L) had elevated Q, values, the remaining three having Q, values that fell within the control range (Table 2 ). There was no significant difference in the mean size of pool (b) between the two groups; however, the individual data again show that J, K and L had elevated Q, values. There were no significant differences between the two groups for fractional transfer rates between the pools (Fig. 3) , but the higher amounts of Zn in pools (a) and (b) in the three enteropathic dogs (J, K and L) were accompanied by a higher rate of flux between pools (b) and (a) (i.e. k,, x Q,). 
Precision of calculated variables
The precision with which the variables derived from the kinetic decay data can be calculated is dependent upon the quality of 'fit' of the exponential decay curve to the experimental data ( Figs. 1 and 2) and of the assumptions which are necessary for the calculation of the derived variables. Thus the average coefficient of variation of the values of Q, in Table 2 was found to be 3.8 YO, but that for Qb was 32.7 %. Considerably more confidence can therefore be placed in the derived values for Q, and kba than on the other variables. However, this cannot explain the apparent differences in the values derived for Q, and Q, for dogs J, K and L. The quality of the 'fit' of the regression curve to the data for these three animals was not significantly different from that for the other animals.
DISCUSSION
The short-term decay of isotopic Zn in the dog appears to follow closely the twocompartment kinetics demonstrated in previous studies over similar time periods in the rat (Lowe et al. 1991 ) and man (Lowe et aI. 1993) . Detailed studies in the rat using radioactive 65Zn have clearly indicated the applicability of this two-compartment model over this time period and although stuhes of such detail are not possible using stable isotopes the data obtained indicate that similar kinetics apply in the dog. Investigation into the physiological location of the two metabolic pools in the rat indicated that pool (a) was composed of plasma Zn and pool (b) was composed of a portion of the liver Zn. The model used for analysis of the two-compartment decay equation takes into account this probable anatomical distribution of the two putative pools, i.e. it assumes that any 'OZn redistributing from pool (b) (a liver Zn pool) must re-enter pool (a) (the plasma) before transfer to other sites (Shipley & Clark, 1972) . The sizes of these pools, when expressed on a body-weight (kg) basis, are remarkably similar in the rat and man (pool (a) rat 0.703 (SE 0-05), man 0720 (SE 0,102) pmollkg; pool (b) rat 2.939 (SE 1*194), man 3.600 (SE 0.929) pmol/kg). If plasma volume in litres is taken to be 5 % body weight, in the rat and human the Zn in pool (a) can be accounted for by serum Zn alone. This is not the case in the dog. The present study reveals that the sizes of both pools (a) and (b) are greater in the dog per kg body weight (Fig. 3) . If the serum volume is taken to be 5 % body weight of the control group (i.e.which contains 1.27 pmol Zn/kg body weight, cannot be located solely in the serum. This implies that pool (a) must include non-serum sources of Zn with which plasma Zn can exchange rapidly.
The two-compartment model is fully compatible with more complex models of Zn metabolism (Wastney et al. 1986; Fainveather-Tait et al. 1993; Miller et al. 1994) . It is clearly not an exact representation of the physiological fluxes of isotope which occur following injection and further useful information might be obtained from protocols involving greater frequency or duration of sampling and more complex modelling (Fairweather-Tait et al. 1993) . However, previous studies have indicated the potential relevance of this simple model both in terms of the anatomical distribution of the exchangeable pools and their response to Zn deficiency (Lowe et al. 1991) .
In the rat the sizes and turnover rates of these metabolic pools are lower in Zn-deficient animals than controls (Lowe et al. 1991) , but no evidence for a similar decline was seen here. In fact the size of Q, was significantly increased in three of the enteropathic animals. This implies an expansion of the extracellular space in these animals. We are unsure of the reason for this, but speculate that an immune reaction to the presence of gluten in the small intestine may result in an increase in extracellular space due to an increase in membrane permeability (Cousins & Leinart, 1988) . Such a hypothesis is supported by studies of intestinal permeability in these animals (Hall & Batt, 1991) .
Enteropathic animals were significantly smaller than those in the control group, but even when the sizes of pools (a) and (b) are expressed in absolute terms there is still a marked increase in the size of pool (a). An expansion of this pool was also unexpectedly observed in human subjects with alcoholic liver disease (Lowe et al. 1993) . It is therefore possible that an expansion of pool (a) may be a relatively non-specific effect of disease in man and animals, but further studies will be required to clarify this.
Plasma Zn concentrations in the enteropathic group were not significantly different from those of control animals and balance results did not indicate any gross loss or accumulation of Zn. Taken together with the kinetic data these results do not appear to indicate a reduction in Zn status in these animals. We are unable to explain the apparent differences between the short-term Zn kinetics in three of the enteropathic animals (J, K and L) compared with the others (Table 2 ). There was no clinical indication that these animals were markedly different from the other diseased dogs, nor was there any relationship between Q, or Q, and e.g. plasma Zn concentration, dietary Zn, age or sex.
In summary it does not appear that gluten-sensitive enteropathy in Irish setters results in low Zn status. There is no significant difference in Zn balance or plasma Zn concentration between healthy and enteropathic dogs. In addition the observed expansion and concurrent increase in Zn flux between the rapidly exchanging Zn pools in some enteropathic animals indicate changes in Zn metabolism which are not consistent with the effects of Zn deficiency.
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